World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
15025
World Ranking
4040
National Ranking
1571

Overview

Joel N. Blankson is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans primarily across Medicine and Immunology and Microbiology, with significant contributions to Infectious Diseases, Immunology, Virology, Molecular Biology, and Animal Science and Zoology.

The work of Joel N. Blankson covers a variety of topics including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Vaccines and immunoinformatics approaches
  • Animal Virus Infections Studies

Their frequent co-authors include:

  • Andrea L. Cox
  • Andrew H. Karaba
  • Aaron A.R. Tobian
  • Caroline C. Garliss
  • Bezawit A. Woldemeskel

Joel N. Blankson's publications have appeared regularly in journals such as:

  • Frontiers in Immunology
  • Journal of Clinical Investigation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • JCI Insight

Notable recent papers include:

  • "Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021" (2021, Nature Medicine)
  • "SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63" (2021, Journal of Clinical Investigation)
  • "The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)" (2021, Clinical Infectious Diseases)
  • "Monocyte-derived macrophages contain persistent latent HIV reservoirs" (2023, Nature Microbiology)
  • "Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA" (2020, Proceedings of the National Academy of Sciences)

Best Publications

  • Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

    Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick

  • Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure

    Ya Chi Ho;Liang Shan;Nina N. Hosmane;Jeffrey Wang

  • The challenge of viral reservoirs in HIV-1 infection.

    Joel N. Blankson;Deborah Persaud;Robert F. Siliciano

  • Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

    Liang Shan;Kai Deng;Neeta S. Shroff;Christine M. Durand

  • A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

    Katherine M. Bruner;Katherine M. Bruner;Zheng Wang;Francesco R. Simonetti;Alexandra M. Bender

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • Maintenance of viral suppression in HIV-1-infected HLA-B*57+elite suppressors despite CTL escape mutations

    Justin R. Bailey;Thomas M. Williams;Robert F. Siliciano;Joel N. Blankson

  • Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

    Joel N. Blankson;Justin R. Bailey;Seema Thayil;Hung Chih Yang

  • Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay

    Gregory M. Laird;Evelyn E. Eisele;S. Alireza Rabi;Jun Lai

  • HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

    Timothy J. Henrich;Hiroyu Hatano;Oliver Bacon;Louise E. Hogan

  • Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy

    Justin R. Bailey;Kara G. Lassen;Hung Chih Yang;Thomas C. Quinn

  • Biphasic Decay of Latently Infected CD4+ T Cells in Acute Human Immunodeficiency Virus Type 1 Infection

    Joel N. Blankson;Diana Finzi;Theodore C. Pierson;Beulah P. Sabundayo

  • HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon

    Michael A. Chattergoon;Rachel Latanich;Jeffrey Quinn;Matthew E. Winter

  • Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1

    Theodore Pierson;Trevor L. Hoffman;Joel Blankson;Diana Finzi

  • Preservation of FoxP3+ Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4+ T-Cell Activation

    Amanda J. Chase;Hung Chih Yang;Hao Zhang;Joel N. Blankson

  • SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.

    Bezawit A. Woldemeskel;Caroline C. Garliss;Joel N. Blankson

  • A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

    Unknown

  • A Simian Immunodeficiency Virus-Infected Macaque Model to Study Viral Reservoirs That Persist During Highly Active Antiretroviral Therapy

    Jason B. Dinoso;S. Alireza Rabi;Joel N. Blankson;Lucio Gama

  • Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients

    Kenneth W Witwer;Andria K Watson;Joel N Blankson;Janice E Clements

  • Monocyte-derived macrophages contain persistent latent HIV reservoirs

    Unknown

  • Elucidating the elite: mechanisms of control in HIV-1 infection

    Karen A. O’Connell;Justin R. Bailey;Joel N. Blankson

  • Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection

    Trevor A. Crowell;Kelly A. Gebo;Joel N. Blankson;P. Todd Korthuis

Frequent Co-Authors

Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Janet D. Siliciano
Janet D. Siliciano Johns Hopkins University School of Medicine
Joseph B. Margolick
Joseph B. Margolick Johns Hopkins University
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine
Stuart C. Ray
Stuart C. Ray Johns Hopkins University School of Medicine
David L. Thomas
David L. Thomas Johns Hopkins University
Richard D. Moore
Richard D. Moore Johns Hopkins University
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open diverse career pathways. One valuable option is pursuing an online cahiim accredited health information management degree. This program prepares graduates for managing healthcare data, crucial for microbiology labs and research settings.

Another promising route is obtaining an online medical billing and coding certificate fast. This certification can lead to roles in medical offices and labs, supporting the administrative side of healthcare strong emphasis on accuracy and compliance.

For those aiming for well-paying roles, exploring medical degrees online that pay well highlights programs combining healthcare knowledge with practical skills that complement a microbiology background well.

Finally, pursuing an accredited online mph programs easy to get into is a great choice for those interested in public health and epidemiology, fields closely linked to microbiology and disease control.

Best Scientists Citing Joel N. Blankson

Trending Scientists